Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 24 December 2008, doi:10.1136/bmj.a3078
Cite this as: BMJ 2008;337:a3078
Features new subtypes of infarction and puts high demands on diagnostic assays
| The first 150 words of the full text of this article appear below. |
The evolution of the definition of acute myocardial infarction tells a fascinating story of medical progress. Between the publication of the initial World Health Organizations classification in 1979,1 and that published by the redefinition committee of the American College of Cardiology, American Heart Association, and European Society of Cardiology in 2000, much of our diagnostic reasoning changed.2 Biochemistry now takes centre stage, and the measurement of cardiac troponins has substantially increased diagnostic sensitivity.
Cardiologists predicted that these changes in diagnostic criteria and sensitivity would increase the incidence of acute myocardial infarction.3 They also predicted that the redefinition would have implications for individual patients and healthcare expenditure. Their predictions turned out to be correct, at least in part. A national registry in Norway found a 33% increase in acute myocardial infarction after the implementation of the 2000 criteria,4 and the Swedish Nationwide Centre of Epidemiology documented an abrupt 14% increase.5
Interest
Dan Atar, professor and head of cardiology
1 Division of Cardiology, Aker University Hospital and Faculty of Medicine, University of Oslo, 0514 Oslo, Norway
dan.atar@online.no
Read all Rapid Responses